이 누리집은 대한민국 공식 전자정부 누리집입니다.
Biz News Korea(Eng)
Seegene set to develop software to apply molecular diagnostics to everyday life
- Collected
- 2016.07.07
- Distributed
- 2016.07.08
- Source
- Go Direct
![Seegene CEO Chun Jong-yoon (right) and DGIST president Shin Sung-cheol signed an MOU on Wednesday to develop technology to help apply molecular diagnostics to everyday life. [Photo = Seegene]](http://file.mk.co.kr/meet/neds/2016/07/image_readtop_2016_487976_14678696792538336.jpg)
Seegene CEO Chun Jong-yoon (right) and DGIST president Shin Sung-cheol signed an MOU on Wednesday to develop technology to help apply molecular diagnostics to everyday life. [Photo = Seegene]
Seegene said it signed a memorandum of understanding with the university on Wednesday on cooperation in research of software to digitize molecular diagnostics technology.
Earlier, the company announced it has developed a platform to develop customized molecular diagnostic reagents, allowing popular access to desired diagnostic reagents and kits. The MOU aims to develop follow-up technology to scale up the number of platform users.
Under the MOU, Seegene and DGIST will work together in various areas: development of software to make the design of high quality oligonucleotides, the key material of molecular diagnostic reagents, utilization of data and information analysis technology, and education in bioinformatics and software.
DGIST will be responsible for convergence research by combining computer engineering and bio-technology, which includes technology to allow a single computer to process large-scale graph data and technology to design oligonucleotides to detect genetic data using big data.
Seegene CEO Chun Jong-yoon said the joint research agreement will be very meaningful to the advancement of the molecular diagnostics market. “If the oligo development software is used, we will be able to dramatically lower the time to develop reagents,” he said.
By Shin Chan-ok
[ⓒ Pulse by Maeil Business News Korea & mk.co.kr, All rights reserved]